| Recruitment status | No longer recruiting |
| Unique ID issued by UMIN | UMIN000013621 |
| Receipt No. | R000015904 |
| Scientific Title | Comparative study for evaluation of endoscopic screening for gastric cancer |
| Date of disclosure of the study information | 2014/04/03 |
| Last modified on | 2019/10/09 (Ver. 3) |
| Basic information | ||
| Public title | Comparative study for evaluation of endoscopic screening for gastric cancer | |
| Acronym | Evaluation study of endoscopic screening for gastric cancer | |
| Scientific Title | Comparative study for evaluation of endoscopic screening for gastric cancer | |
| Scientific Title:Acronym | Evaluation study of endoscopic screening for gastric cancer | |
| Region |
|
|
| Condition | ||
| Condition | Gastric cancer | |
| Classification by specialty |
|
|
| Classification by malignancy | Malignancy | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | Evaluation of mortality reduction from gastric cancer by endoscopic screening |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | Confirmatory |
| Trial characteristics_2 | Pragmatic |
| Developmental phase | Not applicable |
| Assessment | |
| Primary outcomes | Mortality of gastric cancer |
| Key secondary outcomes | 1) All causes mortality/Mortality of all cancers
2) Incidence of gastric cancer 3) Sensitivity/Specificity 4) Rates of adverse effects 5) Cost-effectiveness ratio |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | No treatment |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Prevention | |
| Type of intervention |
|
|
| Interventions/Control_1 | Upper gastrointestinal endoscopy
Helicobacter pylori antibody Pepsinogen |
|
| Interventions/Control_2 | No intervention | |
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1) 61 years at first screening year for intervention
2) Inhabitants who have lived in Niigata city for more than 3 years before the first screening for intervention |
|||
| Key exclusion criteria | 1) Any cancer patients
2) Individuals who have participated in gastric cancer screening in Niigata city within 2 years 3) Patient who have been in therapy for any gastric diseases 4) Patients who have any serious disease and have excluded from target of endoscopic screening for gastric cancer |
|||
| Target sample size | 6000 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Teikyo University | ||||||
| Division name | Faculty of Medical Technology | ||||||
| Zip code | 173-8606 | ||||||
| Address | 2-11-1 Kaga Itabashi-ku, Tokyo | ||||||
| TEL | 03-3964-1211 | ||||||
| chamashi@med.teikyo-u.ac.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Niigata City Medical Association | ||||||
| Division name | Office of Research for Endoscopic Screening | ||||||
| Zip code | 9500914 | ||||||
| Address | 3-3-11, Shichikuyama, Chuo-ku, Niigata-shi, Niigata | ||||||
| TEL | 025-247-8900 | ||||||
| Homepage URL | http://www.esgcr.jp/ | ||||||
| kenshin@esgcr.jp | |||||||
| Sponsor | |
| Institute | Japan Agency for Medical Reaserch and DEvelopment
|
| Institute | |
| Department | |
| Funding Source | |
| Organization | Japan Agency for Medical Reaserch and DEvelopment |
| Organization | |
| Division | |
| Category of Funding Organization | Japanese Governmental office |
| Nationality of Funding Organization | Japan |
| Other related organizations | |
| Co-sponsor | Niigata City Health Community Center
Niigata City Medical Association |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | Teikyo University |
| Address | 2-11-1 Kaga Itabashi-ku, Tokyo |
| Tel | 0339641211 |
| turb-office@teikyo-u.ac.jp | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 新潟市医師会による内視鏡検診実施認定施設(新潟市) |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | No longer recruiting | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000015904 |